RecruitingPhase 3NCT06492616A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceSponsor: Stemline Therapeutics, Inc.Albert Lea, MN · Mankato, MN · Minneapolis, MN · +173 more sites
RecruitingPhase 3NCT05879926Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Sponsor: NRG OncologyAitkin, MN · Baxter, MN · Bemidji, MN · +1223 more sites
RecruitingPhase 3NCT06748222E-Mindfulness Approaches for Living After Breast CancerSponsor: NRG OncologyBrainerd, MN · Duluth, MN · Mankato, MN · +378 more sites
RecruitingPhase 3NCT04852887De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)Sponsor: NRG OncologyAlbert Lea, MN · Burnsville, MN · +809 more sites